Beta Cell Function in Women With Turner Syndrome

This study has been terminated.
(Completed)
Sponsor:
Information provided by:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT00419107
First received: January 5, 2007
Last updated: November 7, 2011
Last verified: November 2011

January 5, 2007
November 7, 2011
November 2004
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00419107 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Beta Cell Function in Women With Turner Syndrome
Beta Cell Function in Women With Turner Syndrome

Diabetes is more frequent in women with Turner syndrome. The purpose of this study is to see, in what ways the glucose metabolism is different in this study population. The hypothesis is that women with Turner Syndrome have an impaired insulin production (beta cell function).

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Blood samples.

Non-Probability Sample

13 women with TS and 12 control women

Turner Syndrome
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
25
January 2007
Not Provided

Inclusion Criteria:

  • Turner syndrome

Exclusion Criteria:

  • Diagnosed diabetes
  • BMI>30
  • Untreated cardiac or thyroid disease
  • Cancer illness
Female
20 Years to 40 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Denmark
 
NCT00419107
20040108
Not Provided
Jens Sandahl Christiansen, Aarhus University Hospital, Aarhus, Denmark
University of Aarhus
Not Provided
Principal Investigator: Jens Sandahl Christiansen, prof. dr.med
University of Aarhus
November 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP